TROFOCARD (Mono Magnesium- L-Aspartate Hydrochloride Trihydrate) & TROFOCARD MAX (Magnesium-L-Aspartate Hydrochloride)

Product description

INDICATIONS: Established magnesium deficiency. Magnesiotherapy.

TROFOCARD
GASTRORESISTANT TABLETS: 614,8mg (60.77 Mg2+)Magnesium-L Aspartate /gr tablets. (BT x 30gr. tablets)INJECTABLE SOLUTION: 614,8mg (60.77 Mg2+)Magnesium-L Aspartate/ampoule (BT x 6 ampoules x 5ml & BT x 12 ampoules x 5ml)
GR. OR. SD.: 1229,6mg (121.5 Mg2+) Magnesium-L-Aspartate/sach. (BT x 20 sach. 5g)
GR. OR. SD.:1229,6mg (121.5 Mg2+) Magnesium-L-Aspartate/sach. (BT x 20 sticks 5g)

TROFOCARD MAX
FILM-COATED TABLETS: 1229.6 (121.56Mg++) Magnesium-L  Aspartate/f.c.tablets (BT x 30 f.c.tablets)
GR. OR. SD.: 2,459.2 (243 Mg++) mg/sachet,(BT x 20 sachets x 5 g)

Read more

Specifications

Categories Finished Dosage Forms
Sales markets Africa; Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied from Greece

More products from Uni-Pharma SA

View all our products (45)
TROFOCARD (Mono Magnesium- L-Aspartate Hydrochloride Trihydrate) & TROFOCARD MAX (Magnesium-L-Aspartate Hydrochloride)

Contact information

Address

Telephone

Website

View all contact information
Curia - From Curiosity to Cure

Curia - From Curiosity to Cure

SACMI INNOVATION

SACMI INNOVATION

Your trusted end-to-end CDMO partner

Your trusted end-to-end CDMO partner

Elevate your expectations. Demand more from your CDMO.

Elevate your expectations. Demand more from your CDMO.

Our Services for You

Our Services for You